Loading...
  • Twitter
  • Facebook
  • Google
  • Twitter
  • Facebook
  • Google
fr

News

Articles dans la catégorie "Biotechnologie"
Posté: il y a 3 heures
Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here are the top industrial biotechnology companies in Europe making...
Posté: Hier, 14:10
The Belgian company Imcyse has raised €35M in a Series B round to develop a potential cure for chronic autoimmune conditions including type 1 diabetes and multiple sclerosis. Imcyse will use the money...
Posté: Hier, 11:59
Phase II results from Dutch biotech CyTuVax show its enhanced hepatitis B vaccine reduces non-responders by 13%. Around 15% of people receiving vaccines for hepatitis B fail to produce antibodies that...
Posté: Juin 17
An anti-aging dietary supplement developed by the Swiss biotech Amazentis to combat age-related muscle weakening has improved the health of muscle cells in a first-in-human study. Mitochondria are par...
Posté: Juin 17
One of the greatest challenges faced by researchers in preclinical oncology studies is the translatability of animal models. Mimicking human diseases accurately to investigate the effects of novel the...
Posté: Juin 17
Artificial intelligence promises to use the power of data to solve some of the biggest problems of our time. But can it help us treat a disease as complex as cancer? Artificial intelligence and machin...
Posté: Juin 14
Zynteglo, a gene therapy developed by the US company bluebird bio for the treatment of beta-thalassemia, will cost European healthcare systems more than €1.5M per patient. Following the approval of th...
Posté: Juin 14
The hearing loss biotech Sensorion has issued bonds to raise €20M, which it will use to fund the phase II development for first-in-class drugs treating hearing loss and severe vertigo. The money will ...
Posté: Juin 14
DelSiTech is a Finnish company developing injectable silica gel implants that release drugs slowly over time, causing fewer side effects and helping patients stick to their treatment regimen. Mission:...
Posté: Juin 13
ADC Therapeutics has raised €67M ($76M) as part of a Series E round to fund the final push of an antibody-drug conjugate treatment for drug-resistant blood cancer into the market. With the latest fund...
Pages : 1 2 3 4 5 6 7 8 9 10 ... » »»